Advanced and/or Metastatic Solid Tumours
3 clinical trials · Condition
◉ Watch Advanced and/or Metastatic Solid Tumours
| Record | Firm | Date |
|---|---|---|
| Study of CB307 in Patients With Advanced and/or Metastatic PSMA-positive Tumours. (NCT04839991) | Crescendo Biologics Ltd. | 2021-06-08 |
| Phase I Study of Nimotuzumab in Solid Tumours (NCT00369252) | YM BioSciences | 2005-06-01 |
Track Advanced and/or Metastatic Solid Tumours automatically
Every clearance here is in the API, with alerts when new ones post.